{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:25Z","timestamp":1792783165666,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"American Academy of Neurology \/ American Brain Foundation","award":["Clinical Research Training Fellowship"],"award-info":[{"award-number":["Clinical Research Training Fellowship"]}],"id":[{"id":"https:\/\/ror.org\/00xxxe629","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00415-019-09230-2","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T02:49:12Z","timestamp":1549853352000},"page":"1007-1015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Sleep disturbances are common in patients with autoimmune encephalitis"],"prefix":"10.1007","volume":"266","author":[{"given":"Margaret S.","family":"Blattner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela S.","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Bucelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"9230_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378:840\u2013851","journal-title":"N Engl J Med"},{"key":"9230_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP (2018) Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 83:166\u2013177","journal-title":"Ann Neurol"},{"key":"9230_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Hoftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Pruss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostasy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404","journal-title":"Lancet Neurol"},{"key":"9230_CR4","first-page":"538","volume":"22","author":"A McKeon","year":"2016","unstructured":"McKeon A (2016) Autoimmune encephalopathies and dementias. Continuum (Minneap Minn) 22:538\u2013558","journal-title":"Continuum (Minneap Minn)"},{"key":"9230_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","volume":"74","author":"C Finke","year":"2017","unstructured":"Finke C, Pruss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Munte T, Deuschl G, Ruprecht K, Stocker W, Wandinger KP, Paul F, Bartsch T (2017) Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 74:50\u201359","journal-title":"JAMA Neurol"},{"key":"9230_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","volume":"82","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ (2017) Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol 82:79\u201392","journal-title":"Ann Neurol"},{"key":"9230_CR7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1017\/cjn.2018.33","volume":"45","author":"J Hebert","year":"2018","unstructured":"Hebert J, Day GS, Steriade C, Wennberg RA, Tang-Wai DF (2018) Long-term cognitive outcomes in patients with autoimmune encephalitis. Can J Neurol Sci 45:540\u2013544","journal-title":"Can J Neurol Sci"},{"key":"9230_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/s-0038-1660480","volume":"38","author":"JM Long","year":"2018","unstructured":"Long JM, Day GS (2018) Autoimmune dementia. Semin Neurol 38:303\u2013315","journal-title":"Semin Neurol"},{"key":"9230_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S2215-0366(17)30330-9","volume":"4","author":"M Peer","year":"2017","unstructured":"Peer M, Pruss H, Ben-Dayan I, Paul F, Arzy S, Finke C (2017) Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study. Lancet Psychiatry 4:768\u2013774","journal-title":"Lancet Psychiatry"},{"key":"9230_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165","journal-title":"Lancet Neurol"},{"key":"9230_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.sleep.2015.11.012","volume":"21","author":"DA Barone","year":"2016","unstructured":"Barone DA, Krieger AC (2016) Sleep disturbances in voltage-gated potassium channel antibody syndrome. Sleep Med 21:171\u2013173","journal-title":"Sleep Med"},{"key":"9230_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/archneurol.2011.106","volume":"68","author":"JR Cornelius","year":"2011","unstructured":"Cornelius JR, Pittock SJ, McKeon A, Lennon VA, Aston PA, Josephs KA, Tippmann-Peikert M, Silber MH (2011) Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol 68:733\u2013738","journal-title":"Arch Neurol"},{"key":"9230_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ana.20693","volume":"59","author":"A Iranzo","year":"2006","unstructured":"Iranzo A, Graus F, Clover L, Morera J, Bruna J, Vilar C, Martinez-Rodriguez JE, Vincent A, Santamaria J (2006) Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol 59:178\u2013181","journal-title":"Ann Neurol"},{"key":"9230_CR14","first-page":"575","volume":"45","author":"N Kawamura","year":"2005","unstructured":"Kawamura N, Kawajiri M, Ohyagi Y, Minohara M, Murai H, Kira J (2005) A patient with paraneoplastic limbic encephalitis induced by breast cancer presenting with hypersomnia. Rinsho Shinkeigaku 45:575\u2013578","journal-title":"Rinsho Shinkeigaku"},{"key":"9230_CR15","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","volume":"83","author":"WO Tobin","year":"2014","unstructured":"Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A (2014) DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology 83:1797\u20131803","journal-title":"Neurology"},{"key":"9230_CR16","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y, Hogl B, Bataller L, Bruggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Marti MJ, Montojo T, Perez-Perez J, Puertas I, Seitz C, Simabukuro M, Tellez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaria J, Dalmau J (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88:1736\u20131743","journal-title":"Neurology"},{"key":"9230_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.clineuro.2012.10.031","volume":"115","author":"KN Anderson","year":"2013","unstructured":"Anderson KN, Kelly TP, Griffiths TD (2013) Primary sleep disorders can cause long-term sleep disturbance in patients with autoimmune mediated limbic encephalitis. Clin Neurol Neurosurg 115:1079\u20131082","journal-title":"Clin Neurol Neurosurg"},{"key":"9230_CR18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","volume":"15","author":"R Allen","year":"2014","unstructured":"Allen R, Picchietti D, Garcia-Borreguero D, Ondo W, Walters A, Winkelman J, Zucconi M, Ferri R, Trenkwalder C, Lee H, Group IRLSS (2014) Restless legs syndrome\/Willis\u2013Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria\u2014history, rationale, description, and significance. Sleep Med 15:860\u2013873","journal-title":"Sleep Med"},{"key":"9230_CR19","unstructured":"Berry RB, Brooks R, Gamaldo CE, et al. for the American Academy of Sleep Medicine (2012). The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, Version 2.0. American Academy of Sleep Medicine, Darien, IL"},{"key":"9230_CR20","unstructured":"Berry RB, Brooks R, Gamaldo CE, et al. for the American Academy of Sleep Medicine (2016) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, Version 2.3. American Academy of Sleep Medicine, Darien, IL"},{"key":"9230_CR21","first-page":"867","volume":"38","author":"T Mitterling","year":"2015","unstructured":"Mitterling T, Hogl B, Schonwald SV, Hackner H, Gabelia D, Biermayr M, Frauscher B (2015) Sleep and respiration in 100 healthy caucasian sleepers\u2014a polysomnographic study according to American Academy of Sleep Medicine standards. Sleep 38:867\u2013875","journal-title":"Sleep"},{"key":"9230_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/NRL.0000000000000171","volume":"23","author":"AE Kim","year":"2018","unstructured":"Kim AE, Kang P, Bucelli RC, Ferguson CJ, Schmidt RE, Varadhachary AS, Day GS (2018) Autoimmune encephalitis with multiple autoantibodies: a diagnostic and therapeutic challenge. Neurologist 23:55\u201359","journal-title":"Neurologist"},{"issue":"2","key":"9230_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00415-018-9153-8","volume":"266","author":"O Laurido-Soto","year":"2019","unstructured":"Laurido-Soto O, Brier MR, Simon LE, McCullough A, Bucelli RC, Day GS (2019) Patient characteristics and outcome associations in AMPA receptor encephalitis. J Neurol 266(2):450\u2013460","journal-title":"J Neurol"},{"key":"9230_CR24","first-page":"1305","volume":"70","author":"Y Dauvilliers","year":"2013","unstructured":"Dauvilliers Y, Bauer J, Rigau V, Lalloyer N, Labauge P, Carlander B, Liblau R, Peyron C, Lassmann H (2013) Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy. JAMA Neurol 70:1305\u20131310","journal-title":"JAMA Neurol"},{"key":"9230_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1212\/01.WNL.0000101718.92619.67","volume":"62","author":"S Overeem","year":"2004","unstructured":"Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J, Lammers GJ (2004) Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 62:138\u2013140","journal-title":"Neurology"},{"key":"9230_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/0304-3940(87)90446-0","volume":"79","author":"B Hars","year":"1987","unstructured":"Hars B, Hennevin E (1987) Impairment of learning by cueing during postlearning slow-wave sleep in rats. Neurosci Lett 79:290\u2013294","journal-title":"Neurosci Lett"},{"key":"9230_CR27","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/j.1460-9568.2009.06654.x","volume":"29","author":"M Molle","year":"2009","unstructured":"Molle M, Eschenko O, Gais S, Sara SJ, Born J (2009) The influence of learning on sleep slow oscillations and associated spindles and ripples in humans and rats. Eur J Neurosci 29:1071\u20131081","journal-title":"Eur J Neurosci"},{"key":"9230_CR28","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1523\/JNEUROSCI.5274-13.2014","volume":"34","author":"DC Barnes","year":"2014","unstructured":"Barnes DC, Wilson DA (2014) Slow-wave sleep-imposed replay modulates both strength and precision of memory. J Neurosci 34:5134\u20135142","journal-title":"J Neurosci"},{"key":"9230_CR29","doi-asserted-by":"publisher","first-page":"12328","DOI":"10.1523\/JNEUROSCI.2463-15.2015","volume":"35","author":"SA Cairney","year":"2015","unstructured":"Cairney SA, Ashton JE, Roshchupkina AA, Sobczak JM (2015) A dual role for sleep spindles in sleep-dependent memory consolidation? J Neurosci 35:12328\u201312330","journal-title":"J Neurosci"},{"key":"9230_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1469-8986.2007.00623.x","volume":"45","author":"IW Saxvig","year":"2008","unstructured":"Saxvig IW, Lundervold AJ, Gronli J, Ursin R, Bjorvatn B, Portas CM (2008) The effect of a REM sleep deprivation procedure on different aspects of memory function in humans. Psychophysiology 45:309\u2013317","journal-title":"Psychophysiology"},{"key":"9230_CR31","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1093\/brain\/awx148","volume":"140","author":"YS Ju","year":"2017","unstructured":"Ju YS, Ooms SJ, Sutphen C, Macauley SL, Zangrilli MA, Jerome G, Fagan AM, Mignot E, Zempel JM, Claassen J, Holtzman DM (2017) Slow wave sleep disruption increases cerebrospinal fluid amyloid-beta levels. Brain 140:2104\u20132111","journal-title":"Brain"},{"key":"9230_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6550","author":"BP Lucey","year":"2019","unstructured":"Lucey BP, McCullough A, Landsness EC, Toedebusch CD, McLeland JS, Zaza AM, Fagan AM, McCue L, Xiong C, Morris JC, Benzinger TLS, Holtzman DM (2019) Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer\u2019s disease. Sci Transl Med. \n                    https:\/\/doi.org\/10.1126\/scitranslmed.aau6550","journal-title":"Sci Transl Med"},{"key":"9230_CR33","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1038\/emm.2014.121","volume":"47","author":"ES Musiek","year":"2015","unstructured":"Musiek ES, Xiong DD, Holtzman DM (2015) Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp Mol Med 47:e148","journal-title":"Exp Mol Med"},{"key":"9230_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nrneurol.2015.232","volume":"12","author":"I Fyfe","year":"2015","unstructured":"Fyfe I (2015) Sleep disorder deficits suggest signature for early Parkinson disease. Nat Rev Neurol 12:3\u20133","journal-title":"Nat Rev Neurol"},{"key":"9230_CR35","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00415-012-6505-7","volume":"259","author":"M Louter","year":"2012","unstructured":"Louter M, Aarden WC, Lion J, Bloem BR, Overeem S (2012) Recognition and diagnosis of sleep disorders in Parkinson\u2019s disease. J Neurol 259:2031\u20132040","journal-title":"J Neurol"},{"key":"9230_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.5664\/jcsm.5944","volume":"12","author":"P Kang","year":"2016","unstructured":"Kang P, de Bruin GS, Wang LH, Ward BA, Ances BM, Lim MM, Bucelli RC (2016) Sleep pathology in Creutzfeldt\u2013Jakob disease. J Clin Sleep Med 12:1033\u20131039","journal-title":"J Clin Sleep Med"},{"key":"9230_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/13803395.2017.1329408","volume":"40","author":"GL McKeon","year":"2018","unstructured":"McKeon GL, Robinson GA, Ryan AE, Blum S, Gillis D, Finke C, Scott JG (2018) Cognitive outcomes following anti-N-methyl-d-aspartate receptor encephalitis: a systematic review. J Clin Exp Neuropsychol 40:234\u2013252","journal-title":"J Clin Exp Neuropsychol"},{"key":"9230_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jneuroim.2017.08.010","volume":"312","author":"AK Yeshokumar","year":"2017","unstructured":"Yeshokumar AK, Gordon-Lipkin E, Arenivas A, Cohen J, Venkatesan A, Saylor D, Probasco JC (2017) Neurobehavioral outcomes in autoimmune encephalitis. J Neuroimmunol 312:8\u201314","journal-title":"J Neuroimmunol"},{"key":"9230_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11910-007-0012-8","volume":"7","author":"E Verstraeten","year":"2007","unstructured":"Verstraeten E (2007) Neurocognitive effects of obstructive sleep apnea syndrome. Curr Neurol Neurosci Rep 7:161\u2013166","journal-title":"Curr Neurol Neurosci Rep"},{"key":"9230_CR40","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1378\/chest.08-2336","volume":"135","author":"CH Lee","year":"2009","unstructured":"Lee CH, Khoo SM, Tai BC, Chong EY, Lau C, Than Y, Shi DX, Lee LC, Kailasam A, Low AF, Teo SG, Tan HC (2009) Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion. Chest 135:1488\u20131495","journal-title":"Chest"},{"key":"9230_CR41","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0140-6736(05)74229-X","volume":"365","author":"JM Marin","year":"2005","unstructured":"Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046\u20131053","journal-title":"Lancet"},{"key":"9230_CR42","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","volume":"342","author":"PE Peppard","year":"2000","unstructured":"Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378\u20131384","journal-title":"N Engl J Med"},{"key":"9230_CR43","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1212\/WNL.0000000000006776","volume":"92","author":"S Sivathamboo","year":"2019","unstructured":"Sivathamboo S, Farrand S, Chen Z, White EJ, Pattichis AA, Hollis C, Carino J, Roberts CJ, Minogue T, Jones NC, Yerra R, French C, Perucca P, Kwan P, Velakoulis D, O\u2019Brien TJ, Goldin J (2019) Sleep-disordered breathing among patients admitted for inpatient video-EEG monitoring. Neurology 92:e194\u2013e204","journal-title":"Neurology"},{"key":"9230_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/brain\/123.2.331","volume":"123","author":"EJ Olson","year":"2000","unstructured":"Olson EJ, Boeve BF, Silber MH (2000) Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 123:331\u2013339","journal-title":"Brain"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09230-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T19:07:59Z","timestamp":1581361679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09230-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["9230"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09230-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all the individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"On behalf of all the authors, the corresponding author states that there are no conflicts of interest. Dr. Blattner has no disclosures to report. Dr. de Bruin has equity in Neuroquestions, LLC. Dr. Bucelli receives an annual gift from a patient\u2019s family for Parsonage-Turner research; served on an advisory board for MT Pharma; and has equity in Neuroquestions, LLC. Dr. Day has served as a topic editor on dementia for DynaMed Plus (EBSCO Industries, Inc) and as clinical director for the Anti-NMDA Receptor Encephalitis Foundation (uncompensated). He receives research\/grant support from The American Academy of Neurology\/American Brain Foundation, Avid Radiopharmaceuticals, the Foundation for Barnes Jewish Hospital, and the National Institutes of Health (P01AG03991, R56AG057195, U01AG057195) and holds stock in ANI Pharmaceuticals, Inc. Dr. Day has provided record review and expert medical testimony on legal cases pertaining to the\u00a0management of Wernicke encephalopathy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}